Literature DB >> 30363368

Examination of the vascularization of fetal kidney with three-dimensional power Doppler technique in pregnancies complicated by increased maternal blood pressure.

Andrea Suranyi1, Miklos Nogrady1, Abel Altorjay1, Tibor Nyari2, Gabor Nemeth1.   

Abstract

The goal of this study was to investigate the fetal renal vascularization during the third trimester of gestation and the perinatal outcome in pregnancies diagnosed with hypertension. Depending on the medical history, the cases were divided into two groups: chronic hypertension (CHT) group and gestational hypertension (GHT) group. The vascularization and the volume of kidneys were observed in prenatal period by three-dimensional ultrasound. We monitored gestations and perinatal complications. Renal volume and vascularization were detected in 45 cases complicated by GHT and 21 cases with CHT during the 20-month study period. The alteration in fetal renal volume and vascularization may be an in utero cause of subsequent intrauterine and neonatal complications, such as cesarean section because of fetal distress (36%), perinatal infection (24%), treatment in neonatal intensive care unit (39%), or increased perinatal mortality (1%) in affected cases. The results demonstrate that fetuses with depressed vascularization of medullae had 1.5 times the risk of an abnormal outcome compared with the control group. The volume of kidneys had a strong correlation with their vascularization. Detailed ultrasound examinations of renal parenchyma appear to be useful for the prenatal diagnosis of intrauterine hypoxia, allowing the detection of potential pathological fetal conditions in utero.

Entities:  

Keywords:  fetus; kidney; power Doppler technique; prenatal diagnosis; renal function; three-dimensional ultrasound

Year:  2018        PMID: 30363368      PMCID: PMC6167631          DOI: 10.1556/1646.10.2018.15

Source DB:  PubMed          Journal:  Interv Med Appl Sci        ISSN: 2061-1617


Introduction

Several ultrasound parameters have been proposed as predictors of long-term renal function, such as amniotic fluid index and evaluation of renal parenchyma. However, studies assessing these parameters have not sufficiently yielded high sensitivities and specificities to ensure accurate counseling using ultrasound alone [1-4]. Three-dimensional (3D) quantification of blood flow with the help of power Doppler and virtual organ computer-aided analysis (VOCAL) program provides an estimation of three-dimensional power Doppler (3-DPD) vascular indices: vascularization index (VI), flow index (FI), and vascularization flow index (VFI) [5]. 3-DPD indices reflect not only the blood flow but also the vascularization of the organ as well. A recent study revealed [6] a linear correlation between vascular indices and real blood flow in placental cotyledons in an animal model. Furthermore, these indices have also been studied in some fetal organs and particularly in placenta to predict postnatal prognosis in fetuses displaying intrauterine growth restriction [7]. The screening of the urogenital tract is a very important investigation during pregnancy. The pathological kidney parameters refer to pathological renal development and function. As it is widely known that fetuses with renal failure have poor perinatal outcome, this study aimed at evaluation of renal vascularization using renal 3-DPD technique to verify possible correlation of vascular indices to postnatal prognosis. Hypertensive disorders of pregnancy (HDP) are a major cause of lethal complications in pregnant women [8]. Hypertensive disorders are present in approximately 5%–10% of pregnancies and preeclampsia (PE) complicating about 3% of pregnancies [9]. A World Health Organization review identified hypertension as the single leading cause of maternal mortality in industrialized countries, accounting for 16% of maternal deaths [10]. HDP also causes increased fetal and neonatal death [9, 11–13]. Since 2014, there is a new classification for HDP, which includes chronic hypertension (CHT), gestational hypertension (GHT), PE, de novo or superimposed on CHT, and white coat hypertension [14]. GHT is represented by the disease in placenta with deteriorated function. The CHT is classified as primary or secondary high blood pressure. More than 90% of cases of CHT belong to primary hypertension, where underlying primary disease is not found in the background. The remaining 10% pertain to secondary hypertension caused by the illness of other organ systems (kidneys, heart, arteries, or endocrine system). HDP might decrease the exchange of oxygen between the pregnant woman and fetus and results in chronic hypoxia. Acute and chronic hypoxia also induces circulatory centralization and priority of blood flow to vital organs, such as brain, heart, and adrenal glands [15-17]. During this compensatory mechanism, spasms evolve in the blood vessels of the skin, muscles, kidneys, and the abdominal cavity. The ultrasound examination of the fetal kidneys is a non-invasive procedure and is easy to carry out. We hypothesized that these vascular changes in the kidneys might be a good indicator for fetal well-being in HDP. Although HDP very frequently occurs nowadays, limited data are available about the vascularization and volume changes of fetal kidney in maternal hypertension. Our first objective was to survey the vascularization and the volume of fetal kidney in the third trimester of gestation as well as the perinatal outcome in CHT and GHT.

Materials and Methods

A prospective case–control study was conducted at the Department of Obstetrics and Gynecology of the University of Szeged (Szeged, Hungary) during a 20-month-long period between 2013 and 2015. The study group consisted of 107 patients: 41 patients with normal parameters (Q), 45 patients with GHT, and 21 patients with CHT. Inclusion criteria comprised singleton pregnancy complicated by GHT or CHT, maternal disease based on ISSHP [14], and gestational age between 20 and 40 weeks. The GHT and PE are characterized by the new onset of hypertension. The chronic CHT refers to high blood pressure preceding the pregnancy [14]. Controls were fetuses with normal evaluation of morphology at the second trimester scan followed at our department. The patient’s withdrawal from the study and/or unavailability for follow-up belonged to exclusion criteria. Each fetus underwent 3D evaluation of both kidneys to study renal vascularization and volume using a Voluson 730-expert ultrasound machine with 4–8 MHz multifrequency transducer (Kretztechnik, Zipf, Austria). For all cases, power Doppler settings were preestablished before volumetric acquisition of the image: mode cent; smooth: 4/5; FRQ: low; quality: 16; density: 6; enhance: 16; balance: GO150; filter: 2; actual power: 2 dB; pulse repetition frequency: 0.9. 3D acquisition was performed for each kidney separately. Kidney imaging was set up longitudinally with the point of entry of renal artery visualized by power Doppler. Fetal renal volumes were separately measured for each fetal kidney using the VOCAL program pertaining to the computer software 4D view (GE Medical Systems, Austria; version 10.4). Subsequently, 3-DPD (Fig.  was introduced to calculate the vascular indices: VI, FI, and VFI (Fig. . The VI, which corresponds to the color voxel/total voxel ratio, measures the quantity of color voxels in the volume of interest, refers to the blood vessels within the volume under examination, and appears as a percentage (vascularity). The FI is the mean color value of all color voxels and represents the average blood flow intensity from 0 to 100 (blood flow). The VFI demonstrating the weighted color voxel/total voxel ratio integrates the data on vessel presence (vascularity) and the number of blood cells transferred (blood flow). The value range extends from 0 to 100 as well. The fetal kidney image with three-dimensional power Doppler technique Sequential quantification of the fetal renal vasculatization indices (VI, FI, and VFI) prepared by the VOCAL software All cases were followed up in the prenatal period by the staff of our department and in the postnatal period by neonatologists. Two acquisitions per patient were performed by the same operator. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (ethical approval no.: 32/2014) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Statistical Analysis

Statistical analyses of the differences between normal and HDP groups were accomplished. The average and standard deviation (±SD) for FI, VI, and VFI were compared between normal (Q) and GHT and CHT groups. We also calculated the mean and standard deviation of the following values: gestational age at birth, the birthweight, the birthlength, and APGAR scores in the 1st, 5th and 10th minutes. Logistic regression analysis was used to identify the correlation between 3-DPD indices and the fetal outcome. The p values less than 0.05 were considered statistically significant.

Results

The vascular indices of the fetal kidney (VI, FI, and VFI) were significantly decreased (Fig.  in the GHT group compared with the control and CHT group (VI: GHT vs. Q p = 0.000, GHT vs. CHT p = 0.001; FI: GHT vs. Q p = 0.000, GHT vs. CHT p = 0.033; VFI: GHT vs. Q p = 0.000, GHT vs. CHT p = 0.021). There were no significant differences in the volume of the kidneys between the three groups. Vascular indices and volume of the fetal kidney in the control (Q) group (n = 41), chronic hypertension (CHT) group (n = 21), and gestational hypertension (GHT) group (n = 45). The solid triangles imply mean values and the two ends of the vertical lines represent the (±)standard deviations. The symbol * indicates significant differences compared with the Q group. (A) VI: vascularization index, (B) FI: flow index, (C) VFI: vascularization flow index, (D) KV: kidney volume. *p < 0.05 Differences between the APGAR scores (Table : the 1-min APGAR scores were significantly decreased in the GHT group compared with the Q group (p = 0.025). In the CHT group, the 5- (p = 0.042) and 10-min (p = 0.032) APGAR scores were significantly decreased compared with the Q group. Between the rest of the values, no significant difference could be found. After the birth, we measured the pH level from the umbilical vein, the birth weight, and the birth length. There were no significant differences between the three groups (Table . Parametric values about the APGAR scores (Apg), umbilical pH (umb pH), birth weight (BW), and birth length (BL) of newborns Standard deviation values are indicated in the brackets. The symbol * indicates significant difference compared with the Q group. Q: control; CHT: chronic hypertension; GHT: gestational hypertension. p < 0.05 We observed the newborns in neonatal intensive care unit (NICU), if there were respiratory arrest, polycythemia, hypoglycemia, or need for therapy (Table . The newborns needed transportation to the NICU in the CHT group: 21.7% out of group; GHT group: 17.2% out of group; and control group: 2.4% out of group. It made a significant difference (p = 0.021) among the groups. Non-parametric values concerning the percentage of newborns with respiratory arrest, polycythemia, hypoglycemia, or necessity of treatment at NICU Q: control; CHT: chronic hypertension; GHT: gestational hypertension; NICU: neonatal intensive care unit. p < 0.05

Discussion

This is the first study in which the vascularization of the fetal kidney was investigated in HDP. The monitoring of depression of renal vascularization can be quantified and it is significantly lower in fetuses with GHT that may evolve renal circulatory insufficiency, and may provide us with valuable new information helping the maternal care. Contrary to the GHT, the renal vascularization was not reduced in CHT. CHT does not cause reduction of the vascularization in the placenta. In these cases, the human body can compensate the consequences of the hypertension. The number of the newborns was significantly higher in the GHT group requiring neonatal intensive care. This also points to the fact how important it would be to identify patients as soon as possible with GHT, and check up this high-risk group. The power Doppler shows a high sensitivity to depict a vascular tree, because it is based on Doppler signal amplitude rather than average frequency values, unlike the color Doppler. Moreover, it does not generate the effects of aliasing and color maps are independent of the angle of insonation. The 3-DPD not only allows a full and adequate study of the vascular placental tree by identifying the different branches of villi [18, 19] but also produces a quantitative assessment of the number of vessels through the vasculature and blood flow index, by applying flow rates and vascularization. By the 3D method, vascular villi of the first, second, and the third order can be seen and thus a higher percentage is achieved in comparison with 2D Doppler technique. Low VI values are interpreted as a decrease in the number of vessels within the placenta. The decreased FI values can be viewed as a reduction in placental blood flow due to increasing placental resistance. Low VFI values manifest a decrease in the number of vessels in the placenta, as well as a reduction of blood flow. If reduced, the three indices reveal that there is a decrease in speed, intensity, and placental blood perfusion. Fetal-downregulated vascularization had influence on fetal renal development [18, 20]. This is an important conclusion, because it suggests that early identification of women at low risk of HPD can be improved to obtain prophylactic treatment and intense surveillance can be initiated at appropriate time.
Table I

Parametric values about the APGAR scores (Apg), umbilical pH (umb pH), birth weight (BW), and birth length (BL) of newborns

QCHTGHT
Apg 19.41 (0.87)8.82 (1.7)8.71 (1.4)*
Apg 59.9 (0.3)9.44 (1.31)*9.67 (0.62)
Apg 1010 (0.0)9.7 (0.77)*9.88 (0.45)
Umb pH7.26 (0.09)7.24 (0.1)7.25 (0.07)
BW (g)3287 (434)3070 (711)3153 (705)
BL (cm)48.88 (2.63)48.86 (2.44)48.5 (3.45)

Standard deviation values are indicated in the brackets. The symbol * indicates significant difference compared with the Q group. Q: control; CHT: chronic hypertension; GHT: gestational hypertension.

p < 0.05

Table II

Non-parametric values concerning the percentage of newborns with respiratory arrest, polycythemia, hypoglycemia, or necessity of treatment at NICU

Q (n = 41) (%)CHT (n = 23) (%)GHT (n = 64) (%)
Respiratory arrest2.4413.0414.06
Polycythemia2.444.385.36
Hypoglycemia2.440.004.69
Transportation to NICU2.4421.7417.19*

Q: control; CHT: chronic hypertension; GHT: gestational hypertension; NICU: neonatal intensive care unit.

p < 0.05

  19 in total

1.  What is biparietal diameter/kidney length ratio in cases with renal hyperechogenicity?

Authors:  Andrea Surányi; Tibor Nyári; Attila Pál
Journal:  Pediatr Nephrol       Date:  2002-11-14       Impact factor: 3.714

2.  Cardiovascular responses to hypoxemia and acidemia in fetal lambs.

Authors:  H E Cohn; E J Sacks; M A Heymann; A M Rudolph
Journal:  Am J Obstet Gynecol       Date:  1974-11-15       Impact factor: 8.661

3.  Cerebral reactions during intrauterine asphyxia in the sheep. I. Circulation and oxygen consumption in the fetal brain.

Authors:  I Kjellmer; K Karlsson; T Olsson; K G Rosén
Journal:  Pediatr Res       Date:  1974-01       Impact factor: 3.756

4.  Examination of placental three-dimensional power Doppler indices and perinatal outcome in pregnancies complicated by intrauterine growth restriction.

Authors:  András Molnár; Andrea Surányi; Tibor Nyári; Gábor Németh; Attila Pál
Journal:  Int J Gynaecol Obstet       Date:  2015-01-07       Impact factor: 3.561

5.  Fetal renal hyperechogenicity in intrauterine growth retardation: importance and outcome.

Authors:  A Surányi; C Retz; J Rigo; J P Schaaps; J M Foidart
Journal:  Pediatr Nephrol       Date:  2001-07       Impact factor: 3.714

6.  In utero fetal urine analysis and renal histology correlate with the outcome in fetal obstructive uropathies.

Authors:  F Qureshi; S M Jacques; B Seifman; R Quintero; M I Evans; C Smith; M P Johnson
Journal:  Fetal Diagn Ther       Date:  1996 Sep-Oct       Impact factor: 2.587

Review 7.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy.

Authors:  Jennifer A Hutcheon; Sarka Lisonkova; K S Joseph
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-02-18       Impact factor: 5.237

8.  Effects of long-term, high-altitude hypoxemia on ovine fetal cardiac output and blood flow distribution.

Authors:  M Kamitomo; J G Alonso; T Okai; L D Longo; R D Gilbert
Journal:  Am J Obstet Gynecol       Date:  1993-09       Impact factor: 8.661

9.  Pregnancy-induced hypertension and early neonatal death: a case-control study.

Authors:  J Zhang; W W Cai; D J Lee
Journal:  Am J Perinatol       Date:  1993-09       Impact factor: 1.862

10.  The Risk Factors That Predict Chronic Hypertension After Delivery in Women With a History of Hypertensive Disorders of Pregnancy.

Authors:  Ji-Won Hwang; Sung-Ji Park; Soo-Young Oh; Sung-A Chang; Sang-Chol Lee; Seung Woo Park; Duk-Kyung Kim
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.